Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome of infants with cystic fibrosis (CF) compared to that of healthy infants, and how these alterations may adversely affect their health.
Post Tagged with: "cystic fibrosis"
Dartmouth-led Study Provides New Insights into Phage Therapy Design
Results from a new Dartmouth-led study, involving collaborators at the University of Pittsburgh and Yale University and published in the journal PLOS Biology, are providing new insights into the therapeutic potential of bacteriophage (phage) therapy for treating diseases like cystic fibrosis (CF).
Study Shows Important Role Gut Microbes Play in Airway Health in Persons with Cystic Fibrosis
Findings from a new study conducted by a team of researchers at Dartmouth’s Geisel School of Medicine and published in the journal mBio, reflect the important role that the gut microbiome (communities of bacteria) plays in the airway health of persons with cystic fibrosis.
Gift Will Support the Development of New Therapies for Cystic Fibrosis
A $1 million gift from John Flatley and his wife, Kate, to a team of investigators at Dartmouth’s Geisel School of Medicine will provide essential funding to develop new and more effective therapies for people with Cystic Fibrosis.
VIDEO – Taking on Cystic Fibrosis: A Student Story
Dartmouth College undergraduate Sam Neff D ’21 fights cystic fibrosis (CF) every day by following a strict treatment regimen, by contributing to CF research in Geisel’s Lung Biology Center, and by participating in a clinical trial at Dartmouth-Hitchcock.
James Bliska to Lead Dartmouth Cystic Fibrosis Research Cluster
Noted molecular biologist James Bliska, PhD, is joining the Geisel School of Medicine at Dartmouth as a Distinguished Professor in Microbiology and Immunology and senior lead faculty member of the Personalized Treatments for Cystic Fibrosis (CF) Cluster, a cross-Dartmouth group of investigators established to develop innovative, personalized medicine and treatments for CF and lung infections caused by opportunistic pathogens.
Inaugural Munck-Pfefferkorn Grants Bring Research Closer to the Marketplace and Helping Patients
The Geisel School of Medicine has announced the inaugural recipients of the annual Munck-Pfefferkorn Awards. Named in honor of two luminaries from the medical school, the endowed award funds new biomedical research projects at Geisel that have high potential to benefit patients and to generate future revenue through grants or entrepreneurial endeavors.
Anonymous Gifts Totaling $15 million Fuel Cystic Fibrosis Research at Geisel
A $10 million gift from an anonymous donor combined with a $5 million matching gift, also anonymous, will accelerate research aimed at finding better treatments and ultimately a cure for cystic fibrosis at the Geisel School of Medicine at Dartmouth.